Skip to contentL
Ligand Pharmaceuticals Inc
L
LGNDLigand Pharmaceuticals Inc Q2 2015 · 10-Q
Revenue$18.42M$18.42Mno prior Q2 2014 on file Net Income$23.56M$23.56Mno prior Q2 2014 on file EPS Diluted$1.11$1.11no prior Q2 2014 on file Operating Income$4,365,000— Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ligand Pharmaceuticals Inc · CIK 886163 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$10,029,000— Margins · derivedOperating margin23.7%
Net margin127.9%
ended Jun 30, 2015 · filed Aug 5, 2015 · 36 d after period end